As diabetes care continues to be a significant focus, new treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a exciting evolution in incretin mimetic medications. While all seek https://bookmarketmaven.com/story23075017/retatrutide-vs-tirzepatid-vs-semaglutide-a-direct-analysis